| HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa JW Eaton, LF Johnson, JA Salomon, T Bärnighausen, E Bendavid, ... PLoS medicine 9 (7), e1001245, 2012 | 416 | 2012 |
| Population-level impact, herd immunity, and elimination after human papillomavirus vaccination: a systematic review and meta-analysis of predictions from transmission-dynamic … M Brisson, É Bénard, M Drolet, JA Bogaards, I Baussano, S Vänskä, M Jit, ... The Lancet Public Health 1 (1), e8-e17, 2016 | 265 | 2016 |
| Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical … JW Eaton, NA Menzies, J Stover, V Cambiano, L Chindelevitch, A Cori, ... The Lancet Global Health 2 (1), e23-e34, 2014 | 225 | 2014 |
| Universal test and treat and the HIV epidemic in rural South Africa: a phase 4, open-label, community cluster randomised trial CC Iwuji, J Orne-Gliemann, J Larmarange, E Balestre, R Thiebaut, ... The lancet HIV 5 (3), e116-e125, 2018 | 219 | 2018 |
| The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa JAC Hontelez, SJ de Vlas, R Baltussen, ML Newell, R Bakker, F Tanser, ... Aids 26, S19-S30, 2012 | 170 | 2012 |
| Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study JAC Hontelez, MN Lurie, T Bärnighausen, R Bakker, R Baltussen, ... PLoS medicine 10 (10), e1001534, 2013 | 149 | 2013 |
| Ageing with HIV in south africa JAC Hontelez, MN Lurie, ML Newell, R Bakker, F Tanser, T Bärnighausen, ... Aids 25 (13), 1665-1667, 2011 | 103 | 2011 |
| Priority setting for universal health coverage: we need evidence-informed deliberative processes, not just more evidence on cost-effectiveness R Baltussen, MP Jansen, E Mikkelsen, N Tromp, J Hontelez, L Bijlmakers, ... International journal of health policy and management 5 (11), 615, 2016 | 101 | 2016 |
| HIV treatment as prevention: models, data, and questions—towards evidence-based decision-making HIV Modelling Consortium Treatment as Prevention Editorial Writing Group PLoS Medicine 9 (7), e1001259, 2012 | 95 | 2012 |
| Costs, effects and cost‐effectiveness of breast cancer control in Ghana SG Zelle, KM Nyarko, WK Bosu, M Aikins, LM Niëns, JA Lauer, ... Tropical Medicine & International Health 17 (8), 1031-1043, 2012 | 93 | 2012 |
| Time and money: the true costs of health care utilization for patients receiving ‘free’HIV/TB care and treatment in rural KwaZulu-Natal N Chimbindi, J Bor, ML Newell, F Tanser, R Baltusen, J Hontelez, ... Journal of acquired immune deficiency syndromes (1999) 70 (2), e52, 2015 | 88 | 2015 |
| The impact of the new WHO antiretroviral treatment guidelines on HIV epidemic dynamics and cost in South Africa JAC Hontelez, SJ De Vlas, F Tanser, R Bakker, T Bärnighausen, ... PloS one 6 (7), e21919, 2011 | 70 | 2011 |
| Concerted efforts to control or eliminate neglected tropical diseases: how much health will be gained? SJ de Vlas, WA Stolk, EA le Rutte, JAC Hontelez, R Bakker, DJ Blok, ... PLoS neglected tropical diseases 10 (2), e0004386, 2016 | 64 | 2016 |
| Assessment of epidemic projections using recent HIV survey data in South Africa: a validation analysis of ten mathematical models of HIV epidemiology in the antiretroviral … JW Eaton, N Bacaër, A Bershteyn, V Cambiano, A Cori, RE Dorrington, ... The Lancet Global Health 3 (10), e598-e608, 2015 | 59 | 2015 |
| Long-term financing needs for HIV control in sub-Saharan Africa in 2015–2050: a modelling study R Atun, AY Chang, O Ogbuoji, S Silva, S Resch, J Hontelez, ... BMJ open 6 (3), e009656, 2016 | 52 | 2016 |
| Balancing efficiency, equity and feasibility of HIV treatment in South Africa–development of programmatic guidance R Baltussen, E Mikkelsen, N Tromp, AK Hurtig, J Byskov, Ø Olsen, ... Cost Effectiveness and Resource Allocation 11 (1), 1-9, 2013 | 50 | 2013 |
| Looking upstream to prevent HIV transmission: can interventions with sex workers alter the course of HIV epidemics in Africa as they did in Asia? R Steen, JAC Hontelez, A Veraart, RG White, SJ de Vlas Aids 28 (6), 891-899, 2014 | 49 | 2014 |
| The socioeconomic benefit to individuals of achieving the 2020 targets for five preventive chemotherapy neglected tropical diseases WK Redekop, EJ Lenk, M Luyendijk, C Fitzpatrick, L Niessen, WA Stolk, ... PLoS neglected tropical diseases 11 (1), e0005289, 2017 | 48 | 2017 |
| Evidence for scaling up HIV treatment in sub-Saharan Africa: a call for incorporating health system constraints E Mikkelsen, JAC Hontelez, MPM Jansen, T Bärnighausen, K Hauck, ... PLoS medicine 14 (2), e1002240, 2017 | 46 | 2017 |
| Changing HIV treatment eligibility under health system constraints in sub-Saharan Africa: investment needs, population health gains, and cost-effectiveness JAC Hontelez, AY Chang, O Ogbuoji, SJ de Vlas, T Bärnighausen, R Atun AIDS (London, England) 30 (15), 2341, 2016 | 46 | 2016 |
